The latest price target for Aspira Womens Health (NASDAQ:AWH) was reported by Cantor Fitzgerald on April 10, 2024. The analyst firm set a price target for $3.30 expecting AWH to rise to within 12 months (a possible 111.54% upside). 4 analyst firms have reported ratings in the last year.

The latest analyst rating for Aspira Womens Health (NASDAQ:AWH) was provided by Cantor Fitzgerald, and Aspira Womens Health reiterated their neutral rating.

There is no last upgrade for Aspira Womens Health

The last downgrade for Aspira Womens Health Inc happened on January 20, 2023 when Cantor Fitzgerald changed their price target from $3 to $2 for Aspira Womens Health Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aspira Womens Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aspira Womens Health was filed on April 10, 2024 so you should expect the next rating to be made available sometime around April 10, 2025.

While ratings are subjective and will change, the latest Aspira Womens Health (AWH) rating was a reiterated with a price target of $3.30 to $3.30. The current price Aspira Womens Health (AWH) is trading at is $1.56, which is out of the analyst’s predicted range.